# RECOMBIVAX HB

NDC: 0006-4981
Generic name: Hepatitis B Vaccine (Recombinant)
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRAMUSCULAR, SUBCUTANEOUS
Marketing started: 19860723

FDA application: BLA101066

## Active ingredients

- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 5 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-4981"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-4981

